AzTrials
AzTrials

Children with Cerebral PalsyEVSP-ANAT-CPNCT06131320

Brain Lesion and Visuospatial Impairment in CP Child

An observational study of Children with Cerebral Palsy, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Children with cerebral palsy (CP) show varying degrees of motor impairment and movement disorders whose perceptive-visual contribution has yet to be established. The literature reports that children with CP have more frequent neuro-visual disorders. Read more about this study

Who is it for?
Ages 4 to 18 years
Conditions the study is for
Children with Cerebral Palsy
What is being tested?
PVSE Test and Cerebral MRI
How many people
150 participants
Where
1 siteFrance
Study dates
1 Sep 2022to 2 Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Children coming for out-patient consultation at the paediatric rehabilitation unit of the Hospices Civils de Lyon for a CP diagnosis

Who may be able to join

  • Male or female aged 4 to 18 yo
  • With a CP diagnosis
  • With PVSE test completion during his/her regular follow-up
  • With a cerebral MRI scan during his/her regular follow-up

Who cannot join

  • With an incomplete PVSE test or whose interpretation was deemed unreliable by the rater

Trial locations and contacts

1 site in 1 country.

France1 site
  • Pediatric rehabilitation unit of the Hospices Civils de Lyon

    Bron, 69677

Other trials in France

About this study

Official title: Visuo-spatial Profile in Children with Cerebral Palsy Born At Term or Not and Anatomical Correlation

Children with cerebral palsy (CP) show varying degrees of motor impairment and movement disorders whose perceptive-visual contribution has yet to be established. The literature reports that children with CP have more frequent neuro-visual disorders. The link between the location and size of the brain lesion and neurovisual symptomatology has yet to be explored.

In this retrospective clinical data study, we will investigate in children with PC whether there is an anatomo-clinical correlation between visuo-spatial disorders is the brain injury of interest to the dorsal visual pathway. We will explore the volume of grey and white matter parietal involvement.

To test visuo-spatial disorders, we will use the PVSE (Visuo-Spatial Elementary Perception) test which does not require motor skills or language and is therefore suitable for children with a PC. This test will make it possible to better identify the deficit or deficits in order to adapt an early remediation. It could serve as a reference for comparing several pathologies/etiologies.

Being tested
PVSE Test, Cerebral MRI
Keywords
Cerebral Palsy, child, visuo-spatial disorder, brain lesion
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PVSE TestDiagnostic test

    Completion of the PVSE test

  • Cerebral MRIOther

    Cerebral MRI scan

Study groups in NCT06131320
Study groupRoleWhat they receive
CP childNot described
Receives: Diagnostic Test: PVSE Test; Other: Cerebral MRI
CP child with a PVSE test and a cerebral MRI performed during his/her follow-upNot described
Receives: Diagnostic Test: PVSE Test; Other: Cerebral MRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PVSE test results: total score and 8 sub-scores (length perception, size perception, angle comparison, midline localization, position perception, position selection, occipital score and parietal score.)

    Using normative values of PVSE test, we assess pathological measure inferior outlier limits and subnormal measure below the lower quartile limit

    Measured: At the inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2023
  2. Study start1 Sep 2022
  3. Primary completion31 Dec 2023
  4. Study completion2 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06131320
Sponsor's protocol ID
69HCL23_1053
Acronym
EVSP-ANAT-CP
Status last verified
Nov 2024
First submitted
9 Nov 2023
Last updated
8 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Children with Cerebral Palsy, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PVSE test results: total score and 8 sub-scores (length perception, size perception, angle comparison, midline localization, position perception, position selection, occipital score and parietal score.) (time frame: At the inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in